Government

The biomedical research system has historically been supported by two main pillars: fundamental research on the mechanisms of disease, largely funded by the National Institutes of Health (NIH), and the pharmaceutical industry, which creates products to treat these conditions. Recent advances in biomedical research and health sciences present an opportunity to change how we understand,... Read More

On May 11, 2022, ASHG hosted its second (virtual) Capitol Hill Day. This event brought together 21 Society members from the ASHG Board of Directors, the Government and Public Advocacy Committee (GPAC), and trainee advocates from the Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. During this year’s event, Hill Day participants met... Read More

Published: Wednesday, May 11, 2022, 4:00 PM U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – Today, the American Society of Human Genetics (ASHG) hosted its 2022 Capitol Hill Day bringing together 21 researchers, clinicians and other advocates from across the country to meet with key members of Congress and their staff to discuss shared... Read More

On March 11, Congress passed a massive end-of-year spending package that included $1.5 trillion in fiscal year (FY) 2022 omnibus appropriations.  The package had broad bipartisan support, passing the House on a vote of 361-69 and the Senate on a vote of 68-31.  President Biden later signed it into law before government funding was set... Read More

Last month, ASHG launched the new Advocacy Certificate for Human Genetics and Genomics Trainees (ACGT) program. ACGT is a competitive, year-long program aimed at providing trainee ASHG members pursuing a research or clinical career with an introduction to science policy and human genetics and genomics advocacy. The program is a Government and Public Advocacy Committee... Read More